Salehi, 125 patient vitamin C late treatment study: 10% lower mortality [p=0.56] https://c19p.org/salehic
copied to clipboard
Risk factors of death in mechanically ventilated COVID-19 patients: a retrospective multi-center study
et al., Research Square, doi:10.21203/rs.3.rs-1362678/v1 (Preprint)
Retrospective 125 mechanically ventilated ICU patients in Iran, showing no significant difference with vitamin C treatment in unadjusted results.
|
risk of death, 10.1% lower, RR 0.90, p = 0.56, treatment 22 of 40 (55.0%), control 52 of 85 (61.2%), NNT 16.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
This study is excluded in the after exclusion results of meta
analysis:
unadjusted results with no group details.
Salehi et al., 3/11/2022, retrospective, Iran, Middle East, preprint, mean age 62.0, 11 authors, study period April 2021 - September 2021.
Late treatment
is less effective
is less effective
salehi
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.